Insights

Loading spinner
Gathering insights about InterVene, Inc.

InterVene, Inc. Tech Stack

InterVene, Inc. uses 8 technology products and services including Font Awesome, Google Cloud, RequireJS, and more. Explore InterVene, Inc.'s tech stack below.

  • Font Awesome
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • RequireJS
    Javascript Frameworks
  • SiteGround
    Platform As A Service
  • PHP
    Programming Languages
  • reCAPTCHA
    Security
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics

InterVene, Inc.'s Email Address Formats

InterVene, Inc. uses at least 1 format(s):
InterVene, Inc. Email FormatsExamplePercentage
First@intervene-med.comJohn@intervene-med.com
43%
First.Last@intervene-med.comJohn.Doe@intervene-med.com
7%
Last@intervene-med.comDoe@intervene-med.com
7%
First@intervene-med.comJohn@intervene-med.com
43%

Frequently Asked Questions

What is InterVene, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
InterVene, Inc.'s official website is intervene-med.com and has social profiles on LinkedInCrunchbase.

What is InterVene, Inc.'s NAICS code?

Minus sign iconPlus sign icon
InterVene, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does InterVene, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, InterVene, Inc. has approximately 16 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: J. E.Chief Financial Officer: C. M.Co-Founder, Vp Of R&d: B. C.. Explore InterVene, Inc.'s employee directory with LeadIQ.

What industry does InterVene, Inc. belong to?

Minus sign iconPlus sign icon
InterVene, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does InterVene, Inc. use?

Minus sign iconPlus sign icon
InterVene, Inc.'s tech stack includes Font AwesomeGoogle CloudRequireJSSiteGroundPHPreCAPTCHABootstrapGoogle Analytics.

What is InterVene, Inc.'s email format?

Minus sign iconPlus sign icon
InterVene, Inc.'s email format typically follows the pattern of First@intervene-med.com. Find more InterVene, Inc. email formats with LeadIQ.

How much funding has InterVene, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, InterVene, Inc. has raised $13M in funding. The last funding round occurred on Oct 07, 2024 for $13M.

When was InterVene, Inc. founded?

Minus sign iconPlus sign icon
InterVene, Inc. was founded in 2012.

InterVene, Inc.

Medical Equipment ManufacturingCalifornia, United States11-50 Employees

InterVene Inc. is a medical device company developing innovative technologies for patients suffering from the long-term consequences of venous disease. 
 
The company’s Recana™ Thrombectomy Catheter System is designed to address venous occlusions, including venous in-stent restenosis (ISR) and native vessel obstructions. 

Recana is an investigational device limited by Federal (US) law to investigational use.
 
Based in Redwood City, California, InterVene has assembled an exemplary team of employees, investors, advisors and board members, all possessing extensive vascular and venous interventional market experience.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2012
Employees
11-50

Section iconFunding & Financials

  • $13M

    InterVene, Inc. has raised a total of $13M of funding over 3 rounds. Their latest funding round was raised on Oct 07, 2024 in the amount of $13M.

  • $1M$10M

    InterVene, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $13M

    InterVene, Inc. has raised a total of $13M of funding over 3 rounds. Their latest funding round was raised on Oct 07, 2024 in the amount of $13M.

  • $1M$10M

    InterVene, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.